Developmental toxicity of fungicide carbendazim in female mice
Article first published online: 17 MAR 2011
© 2011 Wiley-Liss, Inc.
Birth Defects Research Part B: Developmental and Reproductive Toxicology
Volume 92, Issue 2, pages 122–130, April 2011
How to Cite
Farag, A., Ebrahim, H., ElMazoudy, R. and Kadous, E. (2011), Developmental toxicity of fungicide carbendazim in female mice. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 92: 122–130. doi: 10.1002/bdrb.20290
- Issue published online: 11 APR 2011
- Article first published online: 17 MAR 2011
- Manuscript Accepted: 8 FEB 2011
- Manuscript Received: 9 JAN 2011
- environmental issues;
- maternal-fetal interactions;
This study investigated the developmental toxicity of carbendazim during the organogenesis period in mice. Mated CD-1 mice were administered carbendazim at dose levels 0, 150, 300, and 600 mg/kg/day by gavage. Body weights, weight gains, and feed consumption were significantly reduced in mice administered with 300 and 600 mg/kg/day. Carbendazim exposure increased maternal levels of cholesterol, triglyceride, glucose, protein, and creatinine; and reduced the levels of estradiol and progesterone in the 300- and 600-mg/kg/day groups. In addition, exposure to carbendazim significantly reduced the number of live fetuses and increased the number of dead and resorptions at the same dose levels. External, visceral, and skeleton malformations were observed in the 300- and 600-mg/kg/day. In conclusion, exposure of pregnant mice to carbendazim induced maternal and developmental toxicity at 300 and 600 mg/kg/day. 150 mg/kg/day carbendazim produced a very slight increase in postimplantation loss, which was within the range of historical controls, and no evidence of maternal toxicity. Birth Defects Res (Part B) 92:122–130, 2011. © 2011 Wiley-Liss, Inc.